Our Work
Upcoming Events
Want to stay informed about important policy, market access, and health economics issues? Join us for our monthly sessions returning in January 2026 to learn more!
Insights
We offer personalized insights and strategy, and spotlight data in a compelling way to shape policy, communicate value, secure reimbursement, and drive patient access.
-
Four Cents per Beneficiary a Month: Breaking Down GLOBE’s Medicare Part B Premium Savings
CMS significantly reduced its projected savings for the GLOBE Model in the final rule. While the model is expected to generate $440 million in Medicare Part B savings, the estimated impact on beneficiary premiums is only about four cents per month.
-
2026 Health Policy Update: Implications for Biopharma Heading Into 2027
Biopharma companies are facing overlapping policy changes across pricing, reimbursement, 340B, PBM reform, and Medicare drug negotiation. Explore the key developments shaping product, portfolio, and market access decisions heading into 2027.
-
FDA’s 2026 Draft Guidance on Payer Communications
FDA’s 2026 draft guidance updates the framework for manufacturer communications with payors, formulary committees, and similar entities. The revised guidance clarifies expectations for drugs and devices, health care economic information, unapproved product communications, and follow-up when previously shared information becomes materially outdated.
Market Access Briefs
A Blend of Core Concepts and Breaking Headlines
-
Patient-Reported Outcomes in Market Access Strategy
Learn how patient-reported outcomes can strengthen market access strategy by informing value propositions, payer evidence, HEOR, and real-world evidence planning.
-
What Are Drug Compendia and Why Are They Important?
What Are Drug Compendia? Drug compendia are comprehensive references that provide detailed information about pharmaceutical products, including their chemical composition, approved and accepted off-label indications, dosages, side effects, interactions, and other important clinical data. Healthcare professionals, regulatory agencies, and payers rely on compendia when developing treatment plans or determining coverage for a specific product and…
-
Pharmacy Benefit Manager (PBM) Reform
PBM Overview Pharmacy Benefit Managers (PBMs) work with health insurers, large employers and other payers to manage prescription drug benefits. The initial role of PBMs was to negotiate reimbursement rates with drug manufacturers, manage prescription drug claims, and reimburse pharmacies for dispensed medications. Since its inception, the role of the PBMs have evolved over time…